The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Tetrac Can Replace Thyroid Hormone During Brain Development in Mouse Mutants Deficient in the Thyroid Hormone Transporter Mct8
Abstract
The monocarboxylate transporter 8 (MCT8) plays a critical role in mediating the uptake of thyroid hormones (THs) into the brain. In patients, inactivating mutations in the MCT8 gene are associated with a severe form of psychomotor retardation and abnormal serum TH levels. Here, we evaluate the therapeutic potential of the TH analog 3,5,3′,5′-tetraiodothyroacetic acid (tetrac) as a replacement for T4 in brain development. Using COS1 cells transfected with TH transporter and deiodinase constructs, we could show that tetrac, albeit not being transported by MCT8, can be metabolized to the TH receptor active compound 3,3′,5-triiodothyroacetic acid (triac) by type 2 deiodinase and inactivated by type 3 deiodinase. Triac in turn is capable of replacing T3 in primary murine cerebellar cultures where it potently stimulates Purkinje cell development. In vivo effects of tetrac were assessed in congenital hypothyroid Pax8-knockout (KO) and Mct8/Pax8 double-KO mice as well as in Mct8-KO and wild-type animals after daily injection of tetrac (400 ng/g body weight) during the first postnatal weeks. This treatment was sufficient to promote TH-dependent neuronal differentiation in the cerebellum, cerebral cortex, and striatum but was ineffective in suppressing hypothalamic TRH expression. In contrast, TSH transcript levels in the pituitary were strongly down-regulated in response to tetrac. Based on our findings we propose that tetrac administration offers the opportunity to provide neurons during the postnatal stage with a potent TH receptor agonist, thereby eventually reducing the neurological damage in patients with MCT8 mutations without deteriorating the thyrotoxic situation in peripheral tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Friesema, E. C., Grueters, A., Biebermann, H., Krude, H., von Moers, A., Reeser, M., Barrett, T. G., Mancilla, E. E., Svensson, J., Kester, M. H., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17226-7 · Cited by 709
Self-citationAbnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8
Trajkovic, M., Visser, T. J., Mittag, J., Horn, S., Lukas, J., Darras, V. M., Raivich, G., Bauer, K., & Heuer, H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28253 · Cited by 353
Self-citationRoberts, L. M., Woodford, K., Zhou, M., Black, D. S., Haggerty, J. E., Tate, E. H., Grindstaff, K. K., Mengesha, W., Raman, C., & Zerangue, N. (2008) · Endocrinology · doi:10.1210/en.2008-0378 · Cited by 320
Dumitrescu, A. M., Liao, X.-H., Weiss, R. E., Millen, K., & Refetoff, S. (2006) · Endocrinology · doi:10.1210/en.2006-0390 · Cited by 318
Ceballos, A., Belinchon, M. M., Sanchez-Mendoza, E., Grijota-Martinez, C., Dumitrescu, A. M., Refetoff, S., Morte, B., & Bernal, J. (2009) · Endocrinology · doi:10.1210/en.2008-1616 · Cited by 173
Local impact of thyroid hormone inactivation
Dentice, M., & Salvatore, D. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0002 · Cited by 143
Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain
Mayerl, S., Visser, T. J., Darras, V. M., Horn, S., & Heuer, H. (2012) · Endocrinology · doi:10.1210/en.2011-1633 · Cited by 138
Self-citationDiiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency
Verge, C. F., Konrad, D., Cohen, M., Di Cosmo, C., Dumitrescu, A. M., Marcinkowski, T., Hameed, S., Hamilton, J., Weiss, R. E., & Refetoff, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2556 · Cited by 134 · cited 1×
“Moreover, application of DITPA to 4 patients with MCT8 mutations resulted in a normalization of the serum TH parameters without causing any overt side effects (21).”
Trajkovic-Arsic, M., Müller, J., Darras, V. M., Groba, C., Lee, S., Weih, D., Bauer, K., Visser, T. J., & Heuer, H. (2010) · Endocrinology · doi:10.1210/en.2010-0593 · Cited by 87
Self-citation
Research works printed but not linked: 48
- Dumitrescu, 2004, A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene, Am J Hum Genet, 74, 168, 10.1086/380999 · DOI · Paper page
- Schwartz, 2005, Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene, Am J Hum Genet, 77, 41, 10.1086/431313 · DOI · Paper page
- Friesema, 2006, Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8, Nat Clin Pract Endocrinol Metab, 2, 512, 10.1038/ncpendmet0262 · DOI
- Refetoff, 2007, Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination, Best Pract Res Clin Endocrinol Metab, 21, 277, 10.1016/j.beem.2007.03.005 · DOI · Paper page
- Friesema, 2010, Genetics and phenomics of thyroid hormone transport by MCT8, Mol Cell Endocrinol, 322, 107, 10.1016/j.mce.2010.01.016 · DOI
- Oppenheimer, 1997, Molecular basis of thyroid hormone-dependent brain development, Endocr Rev, 18, 462
- de Escobar, 2004, Maternal thyroid hormones early in pregnancy and fetal brain development, Best Pract Res Clin Endocrinol Metab, 18, 225, 10.1016/j.beem.2004.03.012 · DOI · Paper page
- Bernal, 2005, Thyroid hormones and brain development, Vitam Horm, 71, 95, 10.1016/S0083-6729(05)71004-9 · DOI · Paper page
- Wemeau, 2008, Beneficial effects of propylthiouracil plus l-thyroxine treatment in a patient with a mutation in MCT8, J Clin Endocrinol Metab, 93, 2084, 10.1210/jc.2007-2719 · DOI
- Wirth, 2009, Neuronal 3′,3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome, J Neurosci, 29, 9439, 10.1523/JNEUROSCI.6055-08.2009 · DOI · Paper page
- Sugiyama, 2003, Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine, J Biol Chem, 278, 43489, 10.1074/jbc.M306933200 · DOI · Paper page
- Tohyama, 2004, Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier, Endocrinology, 145, 4384, 10.1210/en.2004-0058 · DOI
- Ito, 2011, Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys, J Pharm Sci, 100, 3939, 10.1002/jps.22487 · DOI · Paper page
- Di Cosmo, 2009, A thyroid hormone analog with reduced dependence on the monocarboxylate transporter 8 for tissue transport, Endocrinology, 150, 4450, 10.1210/en.2009-0209 · DOI
- Nakamura, 1978, An assessment of the concentration of acetic acid and propionic acid derivatives of 3,5,3′-triiodothyronine in human serum, J Clin Endocrinol Metab, 46, 91, 10.1210/jcem-46-1-91 · DOI
- Engler, 1984, The deiodination of the iodothyronines and of their derivatives in man, Endocr Rev, 5, 151, 10.1210/edrv-5-2-151 · DOI · Paper page
- Wu, 2005, Alternate pathways of thyroid hormone metabolism, Thyroid, 15, 943, 10.1089/thy.2005.15.943 · DOI · Paper page
- Green, 1961, The peripheral metabolism of tri- and tetraiodothyroacetic acids in man, J Clin Endocrinol Metab, 21, 1548, 10.1210/jcem-21-12-1548 · DOI
- Pitt-Rivers, 1953, Physiological activity of the acetic-acid analogues of some iodinated thyronines, Lancet, 265, 234, 10.1016/S0140-6736(53)90164-0 · doi:10.1016/s0140-6736(53)90164-0
- Lerman, 1956, Physiologic activity of triiodo- and tetraiodo-thyroacetic acid in human myxedema, J Clin Endocrinol Metab, 16, 1470, 10.1210/jcem-16-11-1470 · DOI
- Lerman, 1961, Dissociation of response to triiodothyroacetic acid in myxedema: comparison with response to thyroid substance, J Clin Endocrinol Metab, 21, 1044, 10.1210/jcem-21-9-1044 · DOI
- Kunitake, 1989, 3,5,3′-Triiodothyroacetic acid therapy for thyroid hormone resistance, J Clin Endocrinol Metab, 69, 461, 10.1210/jcem-69-2-461 · DOI
- Ueda, 1996, Differences in response of thyrotropin to 3,5,3′-triiodothyronine and 3,5,3′-triiodothyroacetic acid in patients with resistance to thyroid hormone, Thyroid, 6, 563, 10.1089/thy.1996.6.563 · DOI
- Radetti, 1997, Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance, Thyroid, 7, 775, 10.1089/thy.1997.7.775 · DOI
- Messier, 2000, Triac regulation of transcription is T3 receptor isoform- and response element-specific, Mol Cell Endocrinol, 165, 57, 10.1016/S0303-7207(00)00266-5 · DOI
- Menegay, 1989, Pharmacokinetics of 3,5,3′-triiodothyroacetic acid and its effects on serum TSH levels, Acta Endocrinol (Copenh), 121, 651, 10.1530/acta.0.1210651 · DOI
- Liang, 1997, Organ-specific effects of 3,5,3′-triiodothyroacetic acid in rats, Eur J Endocrinol, 137, 537, 10.1530/eje.0.1370537 · DOI · Paper page
- Mansouri, 1998, Follicular cells of the thyroid gland require Pax8 gene function, Nat Genet, 19, 87, 10.1038/ng0598-87 · DOI · Paper page
- Flamant, 2002, Congenital hypothyroid Pax8−/− mutant mice can be rescued by inactivating the TRα gene, Mol Endocrinol, 16, 24
- Heuer, 2003, Thyroid hormone induces cerebellar Purkinje cell development via the thyroid hormone receptor α1, J Neurosci, 23, 10604, 10.1523/JNEUROSCI.23-33-10604.2003 · DOI
- Friedrichsen, 2003, Regulation of iodothyronine deiodinases in the Pax8−/− mouse model of congenital hypothyroidism, Endocrinology, 144, 777, 10.1210/en.2002-220715 · DOI
- Friesema, 2008, Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10, Mol Endocrinol, 22, 1357, 10.1210/me.2007-0112 · DOI · Paper page
- Iniguez, 1996, Cell-specific effects of thyroid hormone on RC3/neurogranin expression in rat brain, Endocrinology, 137, 1032, 10.1210/endo.137.3.8603571 · DOI
- Gilbert, 2007, Thyroid hormone insufficiency during brain development reduces parvalbumin immunoreactivity and inhibitory function in the hippocampus, Endocrinology, 148, 92, 10.1210/en.2006-0164 · DOI
- Namba, 2008, Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter, Eur J Pediatr, 167, 785, 10.1007/s00431-007-0589-6 · DOI
- Sijens, 2008, 1H magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency, J Clin Endocrinol Metab, 93, 1854, 10.1210/jc.2007-2441 · DOI
- Vaurs-Barriere, 2009, Pelizaeus-Merzbacher-like disease presentation of MCT8 mutated male subjects, Ann Neurol, 65, 114, 10.1002/ana.21579 · DOI
- Pacini, 1982, Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization, J Endocrinol Invest, 5, 403, 10.1007/BF03350541 · DOI
- Asteria, 1999, Prenatal diagnosis of thyroid hormone resistance, J Clin Endocrinol Metab, 84, 405, 10.1210/jcem.84.2.5479 · DOI
- Guran, 2009, 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of d-thyroxine and triiodothyroacetic acid (TRIAC), J Pediatr Endocrinol Metab, 22, 971, 10.1515/JPEM.2009.22.10.971 · DOI
- Mellström, 1991, Independent expression of the α and ß c-erbA genes in developing rat brain, Mol Endocrinol, 5, 1339, 10.1210/mend-5-9-1339 · DOI · Paper page
- Bradley, 1992, Spatial and temporal expression of α- and ß thyroid hormone receptor mRNAs, including the ß2-subtype, in the developing mammalian nervous system, J Neurosci, 12, 2288, 10.1523/JNEUROSCI.12-06-02288.1992 · DOI · Paper page
- Wallis, 2010, The thyroid hormone receptor α1 protein is expressed in embryonic postmitotic neurons and persists in most adult neurons, Mol Endocrinol, 24, 1904, 10.1210/me.2010-0175 · DOI
- Gereben, 2005, Pretranslational regulation of type 2 deiodinase, Thyroid, 15, 855, 10.1089/thy.2005.15.855 · DOI
- Williams, 2011, Deiodinases: the balance of thyroid hormone: local control of thyroid hormone action: role of type 2 deiodinase, J Endocrinol, 209, 261, 10.1530/JOE-10-0448 · DOI · Paper page
- Lameloise, 2001, Differences between the effects of thyroxine and tetraiodothyroacetic acid on TSH suppression and cardiac hypertrophy, Eur J Endocrinol, 144, 145, 10.1530/eje.0.1440145 · DOI · Paper page
- Hernandez, 2005, Structure and function of the type 3 deiodinase gene, Thyroid, 15, 865, 10.1089/thy.2005.15.865 · DOI
- Dupre, 2004, Both thyroid hormone receptor (TR)β1 and TRβ2 isoforms contribute to the regulation of hypothalamic thyrotropin-releasing hormone, Endocrinology, 145, 2337, 10.1210/en.2003-1209 · DOI · Paper page
Cited by
Groeneweg, S., van Geest, F. S., Peeters, R. P., Heuer, H., & Visser, W. E. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz008 · Cited by 216
Self-citationZada, D., Tovin, A., Lerer-Goldshtein, T., Vatine, G. D., & Appelbaum, L. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004615 · Cited by 92
Regulation of thyroid-disrupting chemicals to protect the developing brain
Gilbert, M. E., O’Shaughnessy, K. L., & Axelstad, M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa106 · Cited by 83
Thyroid Hormone Transport and Transporters
Braun, D., & Schweizer, U. (2018) · Vitamins and Hormones · doi:10.1016/bs.vh.2017.04.005 · Cited by 74
The colorful diversity of thyroid hormone metabolites
Köhrle, J. (2019) · European Thyroid Journal · doi:10.1159/000497141 · Cited by 67
Metadata
- Authors
- Horn, S., Kersseboom, S., Mayerl, S., Müller, J., Groba, C., Trajkovic-Arsic, M., Ackermann, T., Visser, T. J., & Heuer, H.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2013-01-10
- Volume
- 154
- Issue
- 2
- Pages
- 968-979
- ISSN
- 0013-7227
- 1945-7170
- Cited by
- 78
- References
- 11
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tetrac Can Replace Thyroid Hormone During Brain Development in Mouse Mutants Deficient in the Thyroid Hormone Transporter Mct8. https://app.cochat.ai/papers/10.1210/en.2012-1628
- The paper
- Horn, S., Kersseboom, S., Mayerl, S., Müller, J., Groba, C., Trajkovic-Arsic, M., Ackermann, T., Visser, T. J., & Heuer, H. (2013). Tetrac Can Replace Thyroid Hormone During Brain Development in Mouse Mutants Deficient in the Thyroid Hormone Transporter Mct8. Endocrinology. https://doi.org/10.1210/en.2012-1628
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.